09:15
“Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalized with COVID-19: a self-controlled case series study”
by Mr AU Chi Ho
09:35
“Development of redispersible remdesivir nanoagglomerate for inhaled therapy: Box-Behnken design, optimization, and in vitro aerosol performance”
by Mr CHAN Ho Wan
09:55
“Role of gut microbiota in implantation during in vitro fertilization treatment”
by Ms CHIN Tsz Ching
10:15
“Hip fracture as a predictive marker for the risk of dementia: a retrospective population-based cohort study”
by Mr HSU Warrington W. Q.
10:35
“Effects of matrix metalloproteinase 7 on vascular function in mice with atherosclerosis”
by Ms KONG Li
10:55
“12-18 months clinical sequelae amongst COVID-19 patients: a territory-wide cohort study”
by Mr LAM Chun Hang
11:15
“The mechanisms of apoptotic effect of Garcinone E on colorectal cancer cells”
by Mr LI Renkai
11:35
“Cardiovascular risks and in prostate cancer patients undergoing androgen deprivation therapy in Hong Kong”
by Ms LI Tung Hiu
11:55
“Angiotensin II regulates P25/CDK5 pathway and cellular senescence in endothelial cells”
by Mr SINGH Sandeep
12:15
“Evolving trends in consumption of direct oral anticoagulants in 65 countries from 2008 to 2019”
by Mr YAN Ka Chun
|